BioLineRx to Report Third Quarter 2025 Results on November 24, 2025

Go back to BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.05 --0 (-0%)
Previous Close $2.05    52 Week High $1.63 
Open $2.30    52 Week Low $0.71 
Day High $2.30    P/E N/A 
Day Low $1.99    EPS $0.00 
Volume 8,592       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.05 --0 (-0%)
Previous Close $2.05    52 Week High $1.63 
Open $2.30    52 Week Low $0.71 
Day High $2.30    P/E N/A 
Day Low $1.99    EPS $0.00 
Volume 8,592